Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Vioxx Route To Re-Approval Outlined By FDA As Merck Mulls Options

Executive Summary

Conflicting opinions from FDA advisory committee members on the safety of Vioxx necessitates additional committee consideration prior to re-approval of the COX-2 inhibitor, an FDA memo states
Advertisement

Related Content

GSK’s COX-2 Plans: Complete Cardio Safety Study, Test Efficacy Of Low Doses
GSK’s COX-2 Plans: Complete Cardio Safety Study, Test Efficacy Of Low Doses
COX-2 Review Highlights “Conundrum” Of FDA Drug Safety Regulation
COX-2 Review Highlights “Conundrum” Of FDA Drug Safety Regulation
COX-2 Review Highlights “Conundrum” Of FDA Drug Safety Regulation
Bextra Withdrawn At FDA’s Request; Pfizer Holds Out Hope For Return
Bextra, Vioxx Require Stronger Warnings, Additional Study, Cmte. Finds
Bextra, Vioxx Require Stronger Warnings, Additional Study, Cmte. Finds
Merck After Vioxx: No Merger, But No Big Near-Term Launches

Topics

Advertisement
UsernamePublicRestriction

Register

PS045726

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel